A team of researchers has reported an important advance in the search for better treatments for advanced prostate cancer.
A second prostate-specific membrane antigen (PSMA) PET scan changed treatment plans for nearly half of patients whose first ...
Morning Overview on MSN
A prostate cancer drug halved the odds of the disease spreading
Men diagnosed with high-risk localized prostate cancer now have trial-level evidence that adding the drug apalutamide to ...
Tiny silica nanoparticles engineered to seek out prostate cancer caused tumor cells to self-destruct and supercharged the ...
A new cancer drug may be able to inhibit both tumor growth and the spread of aggressive prostate cancer. This is shown in a ...
Thousands of men with prostate cancer will be offered a more targeted radiotherapy by the NHS which requires just five doses.
Thousands of men with prostate cancer will be offered high-precision NHS radiotherapy to prevent their disease spreading. Highly targeted stereotactic ablative radiotherapy (SABR) is being made ...
Annalisa (Nalis) Merelli is focused on boys’ and men’s health: She looks into reproductive health, trending treatments, screening approaches, mental health, and everything in between.
Researchers at the University of British Columbia have identified a new form of hereditary prostate cancer that, while rare, ...
Prostate cancer is the most common cancer in men in the UK, with more than 55,000 men being diagnosed every year ...
Researchers have uncovered a rare inherited mutation linked to prostate cancer—and it could help identify at-risk families ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results